Terms: = Ovarian cancer AND TCF7L2, ENSG00000148737, 6934, TCF-4 AND Treatment
3 results:
1. Next-generation sequencing shows the genomic features of ovarian clear cell cancer and compares the genetic architectures of high-grade serous ovarian cancer and clear cell carcinoma in ovarian and endometrial tissues.
Gan M; Tai Z; Yu Y; Zhang C; Xu J
PeerJ; 2023; 11():e14653. PubMed ID: 36721777
[TBL] [Abstract] [Full Text] [Related]
2. The Wnt3a/β-catenin/tcf7l2 signaling axis reduces the sensitivity of HER2-positive epithelial ovarian cancer to trastuzumab.
Shen G; Gao Q; Liu F; Zhang Y; Dai M; Zhao T; Cheng M; Xu T; Jin P; Yin W; Huang D; Weng H; Chen W; Ren H; Mu X; Wu X; Hu S
Biochem Biophys Res Commun; 2020 Jun; 526(3):685-691. PubMed ID: 32248976
[TBL] [Abstract] [Full Text] [Related]
3. Vitamin D Suppresses ovarian cancer Growth and Invasion by Targeting Long Non-Coding RNA CCAT2.
Wang L; Zhou S; Guo B
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32230936
[TBL] [Abstract] [Full Text] [Related]
